CLINICAL IMPORTANCE OF B2 GLYCOPROTEIN I ANTIBODIES IN BCR-ABL NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

dc.contributor.authorKocak, M. Z.
dc.contributor.authorDagli, M.
dc.contributor.authorKutlucan, A.
dc.contributor.authorBasturk, A.
dc.contributor.authorUnlu, A.
dc.contributor.authorAcar, H.
dc.contributor.authorKutlucan, L.
dc.date.accessioned2020-03-26T19:23:20Z
dc.date.available2020-03-26T19:23:20Z
dc.date.issued2016
dc.departmentSelçuk Üniversitesien_US
dc.description21st Congress of the European-Hematology-Association -- JUN 09-12, 2016 -- Copenhagen, DENMARKen_US
dc.description.abstract[Abstract not Available]en_US
dc.description.sponsorshipEuropean Hematol Assocen_US
dc.identifier.endpage811en_US
dc.identifier.issn0390-6078en_US
dc.identifier.startpage811en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/33359
dc.identifier.volume101en_US
dc.identifier.wosWOS:000379484603166en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherFERRATA STORTI FOUNDATIONen_US
dc.relation.ispartofHAEMATOLOGICAen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.titleCLINICAL IMPORTANCE OF B2 GLYCOPROTEIN I ANTIBODIES IN BCR-ABL NEGATIVE MYELOPROLIFERATIVE NEOPLASMSen_US
dc.typeConference Objecten_US

Dosyalar